iBio Receives Nasdaq Noncompliance Notice Over Minimum Bid Price Requirement

PUBT · 1d ago
iBio Receives Nasdaq Noncompliance Notice Over Minimum Bid Price Requirement
  • iBio received a Nasdaq deficiency notice November 19, 2026, for failing the $1 minimum closing bid requirement for 30 consecutive business days.
  • The notice has no immediate trading impact; common stock remains listed on the Nasdaq Capital Market under IBIO.
  • The 180-day compliance period ends May 18, 2027; regaining compliance requires at least 10 consecutive business days at $1 or higher.
  • A further 180-day extension depends on meeting Nasdaq eligibility requirements; otherwise, the common stock faces delisting.
  • Management will consider a reverse stock split if necessary to regain compliance and maintain the listing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iBio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001420720-26-000038), on November 20, 2026, and is solely responsible for the information contained therein.